Medical Marijuana Competitors

Innovative Industrial Properties (NYSE:IIPR) and Medical Marijuana (OTCMKTS:MJNA) are both finance companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, valuation, institutional ownership, earnings, profitability, risk and analyst recommendations.

Institutional and Insider Ownership

74.9% of Innovative Industrial Properties shares are owned by institutional investors. 2.9% of Innovative Industrial Properties shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Valuation and Earnings

This table compares Innovative Industrial Properties and Medical Marijuana's revenue, earnings per share and valuation.

Innovative Industrial Properties has higher revenue and earnings than Medical Marijuana.

Analyst Ratings

This is a breakdown of current ratings for Innovative Industrial Properties and Medical Marijuana, as reported by MarketBeat.

Innovative Industrial Properties presently has a consensus price target of $192.4286, suggesting a potential upside of 1.82%. Given Innovative Industrial Properties' higher possible upside, equities research analysts clearly believe Innovative Industrial Properties is more favorable than Medical Marijuana.

Profitability

This table compares Innovative Industrial Properties and Medical Marijuana's net margins, return on equity and return on assets.

Summary

Innovative Industrial Properties beats Medical Marijuana on 8 of the 8 factors compared between the two stocks.

Medical Marijuana (OTCMKTS:MJNA) and GrowGeneration (NASDAQ:GRWG) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, valuation, earnings, profitability, institutional ownership, risk and dividends.

Profitability

This table compares Medical Marijuana and GrowGeneration's net margins, return on equity and return on assets.

Insider & Institutional Ownership

51.3% of GrowGeneration shares are held by institutional investors. 13.6% of GrowGeneration shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Valuation & Earnings

This table compares Medical Marijuana and GrowGeneration's top-line revenue, earnings per share (EPS) and valuation.

GrowGeneration has higher revenue and earnings than Medical Marijuana.

Analyst Recommendations

This is a summary of recent recommendations and price targets for Medical Marijuana and GrowGeneration, as provided by MarketBeat.com.

GrowGeneration has a consensus target price of $49.5714, suggesting a potential downside of 8.24%. Given GrowGeneration's higher possible upside, analysts plainly believe GrowGeneration is more favorable than Medical Marijuana.

Summary

GrowGeneration beats Medical Marijuana on 8 of the 8 factors compared between the two stocks.

Medical Marijuana (OTCMKTS:MJNA) and 22nd Century Group (NYSEAMERICAN:XXII) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, profitability, earnings, institutional ownership, valuation and risk.

Analyst Ratings

This is a summary of recent ratings and price targets for Medical Marijuana and 22nd Century Group, as provided by MarketBeat.

Profitability

This table compares Medical Marijuana and 22nd Century Group's net margins, return on equity and return on assets.

Valuation and Earnings

This table compares Medical Marijuana and 22nd Century Group's top-line revenue, earnings per share (EPS) and valuation.

Summary

22nd Century Group beats Medical Marijuana on 1 of the 1 factors compared between the two stocks.

KushCo (OTCMKTS:KSHB) and Medical Marijuana (OTCMKTS:MJNA) are both multi-sector conglomerates companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, valuation, earnings, dividends, institutional ownership, risk and analyst recommendations.

Earnings & Valuation

This table compares KushCo and Medical Marijuana's top-line revenue, earnings per share (EPS) and valuation.

Medical Marijuana has lower revenue, but higher earnings than KushCo.

Profitability

This table compares KushCo and Medical Marijuana's net margins, return on equity and return on assets.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for KushCo and Medical Marijuana, as provided by MarketBeat.com.

KushCo currently has a consensus target price of $1.8750, suggesting a potential upside of 45.35%. Given KushCo's higher possible upside, research analysts clearly believe KushCo is more favorable than Medical Marijuana.

Institutional and Insider Ownership

0.0% of KushCo shares are held by institutional investors. 17.3% of KushCo shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

KushCo beats Medical Marijuana on 5 of the 8 factors compared between the two stocks.

Medical Marijuana (OTCMKTS:MJNA) and NSAV (OTCMKTS:NSAV) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, risk, valuation, profitability and earnings.

Earnings & Valuation

This table compares Medical Marijuana and NSAV's gross revenue, earnings per share (EPS) and valuation.

Profitability

This table compares Medical Marijuana and NSAV's net margins, return on equity and return on assets.

Analyst Recommendations

This is a breakdown of recent recommendations and price targets for Medical Marijuana and NSAV, as reported by MarketBeat.com.

Medical Marijuana (OTCMKTS:MJNA) and Terra Tech (OTCMKTS:TRTC) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, risk, valuation, profitability and earnings.

Earnings & Valuation

This table compares Medical Marijuana and Terra Tech's gross revenue, earnings per share (EPS) and valuation.

Medical Marijuana has higher earnings, but lower revenue than Terra Tech.

Profitability

This table compares Medical Marijuana and Terra Tech's net margins, return on equity and return on assets.

Analyst Recommendations

This is a breakdown of recent recommendations and price targets for Medical Marijuana and Terra Tech, as reported by MarketBeat.com.

Insider and Institutional Ownership

0.1% of Terra Tech shares are owned by institutional investors. 6.7% of Terra Tech shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.